Genetic signatures in choline and 1‐carbon metabolism are associated with the severity of hepatic steatosis
Open Access
- 4 January 2013
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 27 (4) , 1674-1689
Abstract
Choline metabolism is important for very low‐density lipoprotein secretion, making this nutritional pathway an important contributor to hepatic lipid balance. The purpose of this study was to assess whether the cumulative effects of multiple single nucleotide polymorphisms (SNPs) across genes of choline/1‐carbon metabolism and functionally related pathways increase susceptibility to developing hepatic steatosis. In biopsy‐characterized cases of nonalcoholic fatty liver disease and controls, we assessed 260 SNPs across 21 genes in choline/1‐carbon metabolism. When SNPs were examined individually, using logistic regression, we only identified a single SNP ( PNPLA3 rs738409) that was significantly associated with severity of hepatic steatosis after adjusting for confounders and multiple comparisons ( P =0.02). However, when groupings of SNPs in similar metabolic pathways were defined using unsupervised hierarchical clustering, we identified groups of subjects with shared SNP signatures that were significantly correlated with steatosis burden ( P =0.0002). The lowest and highest steatosis clusters could also be differentiated by ethnicity. However, unique SNP patterns defined steatosis burden irrespective of ethnicity. Our results suggest that analysis of SNP patterns in genes of choline/1‐carbon metabolism may be useful for prediction of severity of steatosis in specific subsets of people, and the metabolic inefficiencies caused by these SNPs should be examined further.—Corbin, K. D., Abdelmalek, M. F., Spencer, M. D., da Costa, K.‐A., Galanko, J. A., Sha, W., Suzuki, A., Guy, C. D., Cardona, D. M., Torquati, A., Diehl, A. M., Zeisel, S. H. Genetic signatures in choline and 1‐carbon metabolism are associated with the severity of hepatic steatosis. FASEB J. 27, 1674–1689 (2013). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health (R01DK055865, P30DK056350)
- National Institutes of Health (DK034987, P30DK056350, NIH/National Institute of Diabetes and Digestive and Kidney Diseases K23 Career Development, K23‐DK062116)
This publication has 56 references indexed in Scilit:
- Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid AcyltransferaseCell Metabolism, 2012
- Molecular mechanisms of epistasis within and between genesTrends in Genetics, 2011
- Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistanceHepatology, 2011
- A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular CarcinomaGastroenterology, 2011
- Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistanceHepatology, 2010
- Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver DiseaseGastroenterology, 2010
- A map of human genome variation from population-scale sequencingNature, 2010
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic SyndromeArchives of Medical Research, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005